Moreover, treatment with AMG 330 led to an upregulation of the immune checkpoint molecule PD-L1 on AML cells and blocking of the PD-1/PD-L1 interaction enhanced AMG 330 mediated cell lysis (140). Here, CD274 is linked to acute myeloid leukemia.